COST

1,075.77

+2.56%↑

81.22

+0.47%↑

142.37

+0.54%↑

191.47

+0.86%↑

PEP

149.11

+0.01%↑

COST

1,075.77

+2.56%↑

81.22

+0.47%↑

142.37

+0.54%↑

191.47

+0.86%↑

PEP

149.11

+0.01%↑

COST

1,075.77

+2.56%↑

81.22

+0.47%↑

142.37

+0.54%↑

191.47

+0.86%↑

PEP

149.11

+0.01%↑

COST

1,075.77

+2.56%↑

81.22

+0.47%↑

142.37

+0.54%↑

191.47

+0.86%↑

PEP

149.11

+0.01%↑

COST

1,075.77

+2.56%↑

81.22

+0.47%↑

142.37

+0.54%↑

191.47

+0.86%↑

PEP

149.11

+0.01%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

4.37 -0.23

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.26

Max

4.46

Schlüsselkennzahlen
By Trading Economics
Einkommen	3.9M -6M
Verkäufe	-5.3M 31M
Gewinnspanne	-19.435
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+51.59% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-92M 149M
Vorheriger Eröffnungskurs	4.6
Vorheriger Schlusskurs	4.37

Nachrichtenstimmung

By Acuity

50%

70 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Mai 2026, 23:10 UTC

Heiße Aktien

Stocks to Watch: Agilysys, XP

18. Mai 2026, 18:44 UTC

Wichtige Markttreiber

Claritev Shares Recover After Comments About DOJ

18. Mai 2026, 23:55 UTC

Ergebnisse

Review & Preview: Earnings' Last Gasp -- Barrons.com

18. Mai 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Mai 2026, 23:47 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Deal -- Market Talk

18. Mai 2026, 23:37 UTC

Market Talk

Gold Rises Amid Hopes for U.S.-Iran Peace Deal -- Market Talk

18. Mai 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology Ju Teng International Shares to Resume Trading on Hong Kong Exchange on May 19

18. Mai 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology: Acquisition of Remaining Ju Teng International Shares to Cost HK$1.91B

18. Mai 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Make Offer for Remainder Shares of Ju Teng International Only After Completion of Stake Purchase

18. Mai 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Acquire 333.71M Ju Teng International Shares for HK$2.20 Each

18. Mai 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Lens Technology to Acquire 27.81% Stake in Ju Teng International for HK$734.17M

18. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. Mai 2026, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

18. Mai 2026, 20:25 UTC

Ergebnisse

Correct: XP 1Q Total Client Assets BRL1.53T

18. Mai 2026, 20:23 UTC

Ergebnisse

XP 1Q Total Client Assets BRL1.53B

18. Mai 2026, 20:19 UTC

Ergebnisse

XP 1Q Adj EPS BRL2.49 >XP

18. Mai 2026, 20:19 UTC

Ergebnisse

XP 1Q Rev BRL4.73B >XP

18. Mai 2026, 19:10 UTC

Market Talk

Oil Presses Higher With No Hormuz Reopening in Sight -- Market Talk

18. Mai 2026, 19:00 UTC

Ergebnisse

5 Stocks with 5% Yields and Market-Beating Returns -- Barrons.com

18. Mai 2026, 18:52 UTC

Market Talk

U.S. Natural Gas Futures Gain As Weather Heats Up -- Market Talk

18. Mai 2026, 18:17 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

NextEra's Dominion Acquisition Unlikely to Spur Wider Utility Consolidation -- Market Talk

18. Mai 2026, 17:22 UTC

Market Talk

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

18. Mai 2026, 16:57 UTC

Akquisitionen, Fusionen, Übernahmen

The Long Regulatory Road Ahead for the NextEra-Dominion Deal -- Barrons.com

18. Mai 2026, 16:57 UTC

Market Talk

Global Energy Roundup: Market Talk

18. Mai 2026, 16:57 UTC

Market Talk

Commodities Higher as Traders Want Physical Assets -- Market Talk

18. Mai 2026, 16:54 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci Doesn't Set Out Financial Details of Deal

18. Mai 2026, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Acquisition of New Brunswick-Based Group Stregthens Presence in Eastern Canada

18. Mai 2026, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Modern Group is Roadwork, Civil Engineering Specialist

18. Mai 2026, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci: Modern Group Made Revenue of Around 50 Mln Euros Last Year

18. Mai 2026, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

Vinci Buys Canada's Modern Group of Companies

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

51.59% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 51.59%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

70 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.